Corrigendum to “Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats” [Life Sci. 224 (2019) 177–186]
Autor: | Chen, Xingxing, Ge, Wenhua, Dong, Tiancheng, Hu, Jie, Chen, Lingzhi, Fan, Xiaofang, Gong, Yongsheng, Zhou, Hao |
---|---|
Zdroj: | In Life Sciences 1 June 2022 298 |
Databáze: | ScienceDirect |
Externí odkaz: |